Akèy › Skleroz Amiotrofik Lateral › Texas › Dallas
Etid klinik pou Skleroz Amiotrofik Lateral nan Dallas, TX
8 etid pou Skleroz Amiotrofik Lateral ap chèche patisipan nan sit nan ak bò kote Dallas (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
MindEx: A Novel, Multifocal, Cognitive Brain-Machine Interface System
Ap rekrite
- UT Southwestern Medical Center, Dallas
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
Ap rekriteFaz 3
- Texas Neurology, Dallas
Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis
Ap rekriteFaz 2
- Zydus US001, Dallas
ASSESS ALL ALS Study
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Texas Neurology, Dallas
PREVENT ALL ALS Study
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Texas Neurology, Dallas
Study of COYA 302 for the Treatment of ALS
Ap rekriteFaz 2/3
- Texas Neurology, PA, Dallas
INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study
Ap rekrite
- University of Texas Southwestern Medical Center (UTSW), Dallas
VOICE: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for Communication Restoration
Ap rekrite
- The University of Texas Southwestern Medical Center, Dallas
Etid Skleroz Amiotrofik Lateral nan lòt vil
- Boston, MA19 etid
- Philadelphia, PA14 etid
- Baltimore, MD13 etid
- Jacksonville, FL13 etid
- New York City, NY11 etid
- San Diego, CA10 etid
- Chicago, IL10 etid
- San Francisco, CA10 etid
- St. Louis, MO9 etid
- Phoenix, AZ8 etid
- Atlanta, GA8 etid
- Seattle, WA7 etid
Lòt etid nan Dallas
- Kansè nan tete55 etid
- Kansè Poumon ki pa ti selil52 etid
- Kansè Metastatik42 etid
- Ensifizyans kadyak42 etid
- Kansè (tout kalite)37 etid
- Kansè pwostat36 etid
- Kansè kolorektal33 etid
- Obèsite30 etid
- Kansè ovè28 etid
- Kansè vejik27 etid
- Kansè poumon27 etid
- Kansè Endomèt24 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.